Obinutuzumab and venetoclax for high-risk CLL: upcoming CLL14 trial
What does the TOURMALINE-MM2 study tell us about the use of ixazomib in multiple myeloma?
The role of transplant in the era of new treatments for lymphoma and CLL
How does an understanding of the microenvironment aid research in CLL?
Changing epigenetic markers in CLL patients on ibrutinib